Differences in clinical manifestations, treatment, and concordance rates with two major sets of criteria for Beh?et’s syndrome for patients in the US and Japan: data from a large, three-center cohort study

详细信息    查看全文

• 作者：Tatsuo Kobayashi (1)
  Mitsumasa Kishimoto (2)
  Christopher J. Swearingen (3)
  Maria T. Filopoulos (5)
  Yuri Ohara (2)
  Yasuharu Tokuda (4)
  Hideto Oshikawa (1)
  Kazuki Yoshida (1)
  Masako Utsunomiya (6)
  Makiko Kimura (1)
  Masato Okada (2)
  Kazuo Matsui (1)
  Yusuf Yazici (5)
  
• 关键词：Beh?et’s syndrome ; Beh?et’s disease ; International Study Group (ISG) criteria ; Japanese criteria ; Manifestation
• 刊名：Modern Rheumatology
• 出版年：2013
• 出版时间：May 2013
• 年：2013
• 卷：23
• 期：3
• 页码：547-553
• 全文大小：192KB
• 参考文献：1. Barnes CG. History and diagnosis. In: Yazici H, Yazici Y, editors. Beh?et’s syndrome. New York: Springer; 2010. p. 7-3.
  2. Mason RM, Barnes CG. Beh?et’s syndrome with arthritis. Ann Rheum Dis. 1969;28:95-03. CrossRef
  3. Ideguchi H, Suda A, Takeno M, Ueda A, Ohno S, Ishigatsubo Y. Beh?et disease: evolution of clinical manifestations. Medicine (Baltimore). 2011;90:125-2. CrossRef
  4. Sakane T, Takeno M, Suzuki N, Inaba G. Beh?et’s disease. N Engl J Med. 1999;341:1284-1. CrossRef
  5. Yurdakul S, Günaydin I, Tüzün Y, Tankurt N, Pazarli H, Ozyazgan Y, et al. The prevalence of Beh?et’s syndrome in a rural area in northern Turkey. J Rheumatol. 1988;15:820-.
  6. Calamia KT, Wilson FC, Icen M, Crowson CS, Gabriel SE, Kremers HM. Epidemiology and clinical characteristics of Beh?et’s disease in the US: a population-based study. Arthritis Rheum. 2009;61:600-. CrossRef
  7. Yurdakul S, Hamuryudan V, Yazici H. Beh?et syndrome. Curr Opin Rheumatol. 2004;16:38-2. CrossRef
  8. Chamberlain MA. Behcet’s syndrome in 32 patients in Yorkshire. Ann Rheum Dis. 1977;36:491-. CrossRef
  9. Davatchi F, Shahram F, Chams-Davatchi C, Shams H, Nadji A, Akhlaghi M, et al. Behcet’s disease: from East to West. Clin Rheumatol. 2010;29:823-3. CrossRef
  10. Shang Y, Han S, Li J, Ren Q, Song F, Chen H. The clinical feature of Beh?et’s disease in Northeastern China. Yonsei Med J. 2009;50:630-. CrossRef
  11. Alpsoy E, Donmez L, Onder M, Gunasti S, Usta A, Karincaoglu Y, et al. Clinical features and natural course of Beh?et’s disease in 661 cases: a multicentre study. Br J Dermatol. 2007;157:901-. CrossRef
  12. Neves FS, Caldas CAM, Lage LV, Goldenstein-Schainberg C, Gon?alves CR. Faraway from the silk route: demographic and clinical features of Beh?et’s disease in 106 Brazilian patients. Clin Rheumatol. 2009;28:543-. CrossRef
  13. Krause I, Yankevich A, Fraser A, Rosner I, Mader R, Zisman D, et al. Prevalence and clinical aspects of Behcet’s disease in the north of Israel. Clin Rheumatol. 2007;26:555-0. CrossRef
  14. Cheng SP, Zhang X-Q. Some special clinical manifestations of Beh?et’s disease—report of illustrative cases and review of literature. Chin J Intern Med. 1980;19:15-2 (in Chinese).
  15. Davatchi F, Shahram F, Akbarian M, Gharibdoost F, Nadji A, Chams C, et al. Accuracy of existing diagnosis criteria for Behcet’s disease. In: Wechsler B, Godeau P, editors. Beh?et’s disease. Excerpta Medica International Congress Series 1037. Amsterdam: Excerpta Medica; 1993. p. 225-.
  16. Davatchi F, Shahram F, Akbarian M, Gharibdoost F, Chams C, Chams H, et al. Classification tree for the diagnosis of Behcet’s disease. In: Wechsler B, Godeau P, editors. Beh?et’s disease. Excerpta Medica International Congress Series 1037. Amsterdam: Excerpta Medica; 1993. p. 245-.
  17. Chang HK, Kim SY. Survey and validation of the criteria for Behcet’s disease recently used in Korea: a suggestion for modification of the International Study Group criteria. J Korean Med Sci. 2003;18:88-2.
  18. Chang HK, Lee SS, Bai HJ, Lee YW, Yoon BY, Lee CH, et al. Validation of the classification criteria commonly used in Korea and a modified set of preliminary criteria for Beh?et’s disease: a multi-center study. Clin Exp Rheumatol. 2004;22:S21-.
  19. International Team for the Revision of the International Criteria for Beh?et’s disease. Evaluation of the International Criteria for Beh?et’s disease (ICBD). Clin Exp Rhumatol. 2006;24 Suppl 42:S13.
  20. International Team for the Revision of the International Criteria for Beh?et’s disease. Revision of the International Criteria for Beh?et’s disease (ICBD). Clin Exp Rhumatol. 2006;24 Suppl 42:S14-.
  21. International Study Group for Beh?et’s Disease. Criteria for diagnosis of Beh?et’s disease. Lancet. 1990;335:1078-0.
  22. Dervis E, Geyik N. Sensitivity and specificity of different diagnostic criteria for Beh?et’s disease in a group of Turkish patients. J Dermatol. 2005;32:266-2.
  23. Beh?et’s Disease Research Committee of Japan. Beh?et’s disease guide to diagnosis of Beh?et’s disease. Jpn J Ophthalmol. 1974;18:291-.
  24. Mizushima Y. Recent research into Beh?et’s disease in Japan. Int J Tissue React. 1988;10:59-5.
  25. Suzuki Kurokawa M, Suzuki N. Behcet’s disease. Clin Exp Med. 2004;4:10-0.
  26. Ferraz MB, Walter SD, Heymann R, Atra E. Sensitivity and specificity of different diagnostic criteria for Beh?et’s disease according to the latent class approach. Br J Rheumatol. 1995;34:932-. CrossRef
  27. O’Neill TW, Rigby AS, Silman AJ, Barnes C. Validation of the International Study Group criteria for Beh?et’s disease. Br J Rheumatol. 1994;33:115-. CrossRef
  28. Tun? R, Uluhan A, Meliko?lu M, Ozyazgan Y, Ozdo?an H, Yazici H. A reassessment of the International Study Group criteria for the diagnosis (classification) of Beh?et’s syndrome. Clin Exp Rheumatol. 2001;19:S45-.
  29. Lewis KA, Graham EM, Stanford MR. Systematic review of ethnic variation in the phenotype of Behcet’s disease. Scand J Rheumatol. 2007;36:1-. CrossRef
  30. Davatchi F, Sadeghi Abdollahi B, Shahram F, Nadji A, Chams-Davatchi C, Shams H, et al. Validation of the International Criteria for Beh?et’s disease (ICBD) in Iran. Int J Rheum Dis. 2010;13:55-0.
  31. Fresko I, Yazici H, Bayrami?li M, Yurdakul S, Mat C. Effect of surgical cleaning of the skin on the pathergy phenomenon in Beh?et’s syndrome. Ann Rheum Dis. 1993;52:619-0. CrossRef
  32. Dil?en N, Koni?e M, Aral O, Ocal L, Inan? M, Gül A. Comparative study of the skin pathergy test with blunt and sharp needles in Beh?et’s disease: confirmed specificity but decreased sensitivity with sharp needles. Ann Rheum Dis. 1993;52:823-. CrossRef
  33. Davatchi F, Chams-Davatchi C, Ghodsi Z, Shahram F, Nadji A, Shams H, et al. Diagnostic value of pathergy test in Behcet’s disease according to the change of incidence over the time. Clin Rheumatol. 2011;30:1151-. CrossRef
  34. Sfikakis PP, Markomichelakis N, Alpsoy E, Assaad-Khalil S, Bodaghi B, Gul A, et al. Anti-TNF therapy in the management of Behcet’s disease—review and basis for recommendations. Rheumatology (Oxford). 2007;46:736-1. CrossRef
  
• 作者单位：Tatsuo Kobayashi (1)
  Mitsumasa Kishimoto (2)
  Christopher J. Swearingen (3)
  Maria T. Filopoulos (5)
  Yuri Ohara (2)
  Yasuharu Tokuda (4)
  Hideto Oshikawa (1)
  Kazuki Yoshida (1)
  Masako Utsunomiya (6)
  Makiko Kimura (1)
  Masato Okada (2)
  Kazuo Matsui (1)
  Yusuf Yazici (5)
  
  1. Department of Rheumatology, Kameda Medical Center, Kamogawa, Japan
  2. Section of Allergy and Rheumatology, St. Luke’s International Hospital, Tokyo, Japan
  3. Biostatistics, Department of Pediatrics, UAMS, Little Rock, AR, USA
  5. Rheumatology, NYU Hospital for Joint Diseases, New York, NY, USA
  4. Institute of Clinical Medicine, Graduate School of Comprehensive Human Sciences, University of Tsukuba, Ibaraki, Japan
  6. Department of Rheumatology, Musashino Red Cross Hospital, Tokyo, Japan
  
• ISSN：1439-7609

文摘

Objective To compare Beh?et’s syndrome (BS) cohorts from the US and Japan in terms of rates of concordance with the International Study Group (ISG) criteria and Japanese criteria, disease manifestations, and treatment. Methods All BS patients seen at the NYU Hospital for Joint Diseases in the US and the Kameda Medical Center and St. Luke’s International Hospital in Japan between 2003 and 2010 were included. Diagnosis of BS was made on the basis of clinical manifestations and the clinical decisions of experienced specialists familiar with BS. We classified the patients into complete and incomplete types based on their symptoms; both complete or incomplete types were assumed to fulfil the Japanese criteria. Results A total of 769 patients (US n?=?634, Japan n?=?135) were reviewed. 61.5?% in the US and 63.7?% in Japan fulfilled the ISG criteria. Similarly, there was no difference in the proportions of US and Japanese patients who fulfilled the Japanese criteria. Japanese patients were less likely to be female and to have genital ulcers, but were more likely to have epididymitis and pulmonary disease. Significantly more patients were treated with colchicine, sulfasalazine/mesalazine, and NSAIDs in Japan, while significantly more patients in the US received first-line immunosuppressants. Conclusions The concordance rates for ISG and Japanese criteria fulfillment in the US and Japan were not significantly different. These findings could help to clarify regional differences in the diagnostic and clinical features of BS.